Navigation Links
Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
Date:2/26/2008

hase 2a study for the treatment of HIV. In addition, the Company is investigating RDEA806 for the treatment of gout. The Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, is in a Phase 1 study in advanced cancer patients and is being investigated for the treatment of inflammatory diseases. Ardea also is developing a next-generation NNRTI for HIV and a next-generation MEK inhibitor for both cancer and inflammatory diseases.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Ardea's goals, including the expected properties and benefits of RDEA806, RDEA119 and its other compounds and the results of clinical and other studies. Risks that contribute to the uncertain nature of the forward-looking statements include: risks related to the outcomes of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with internal development and in-licensing activities. These and other risks and uncertainties are described more fully in Ardea's most recently filed SEC documents, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. Ardea undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. Ardea Biosciences Announces $40 Million Private Placement
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
8. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...erence gel electrophoresis (DIGE) is a relatively ...tial labeling of protein samples using fluorescent...hed by Unlu et al. (1997), uses , cyanine...ted by 2-D gel , electrophoresis. Followi... , can be achieved by scanning the multip...
...avid Anderson, Dominic Andrada, and Richard Grant,... Washington, Seattle, WA 98195 USA , , ...ng four separate enzyme-linked immunosorbent assay... for the viruses of greatest concern: simian , ...us (STLV), herpes B, and simian , immunod...
...llan Gandy, Diana Davis, and Aiguo Zhang, Bio-Rad,...cules, CA 94547 USA , , Introdu...ystem is an integrated system consisting , ...m employs bead-based Luminex , technology...single microplate , well. The Bio-Plex va...
...ure RNA Isolation Kit , Catalog #732-63... , Method , Cell Lysis ,...tissue or fresh tissue to a , tissue grin...ion. Grind , frozen tissue finely in liqu..., Keep tissue frozen until added to the tis...
Other Biology Technology:Imaging and Analysis of DIGE Product Information Sheet, Rev B 2Imaging and Analysis of DIGE Product Information Sheet, Rev B 3Imaging and Analysis of DIGE Product Information Sheet, Rev B 4Imaging and Analysis of DIGE Product Information Sheet, Rev B 5Imaging and Analysis of DIGE Product Information Sheet, Rev B 6Imaging and Analysis of DIGE Product Information Sheet, Rev B 7Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System 2Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System 3Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System 4Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 2Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 3Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 4Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 5Total RNA Isolation From 50100 mg Plant Tissue 2
(Date:10/3/2008)...earch into the life cycle of Atlantic bluefin tuna... North American bluefin mix substantially as juven... These new research findings have critical implica...es of the Atlantic. , Research appearing in the...Dr. Jay Rooker of Texas A&M University and Dr. Dav...
(Date:10/3/2008)... U.S. Senate has confirmed the appointment of Esin...ience at Clemson University, to serve on the Natio...nominated Gulari for the post along with six other...us honor for me as a scientist and an engineer," s...ition to make contributions on a national level. I...
(Date:10/3/2008)...imal species have developed conspicuous traits pro...s in lions, black stripes in some birds and fishes...s for resources and/or contribute to increase the ...hese traits as signals depends on the fact that th...f the bearer. This would be only assured by the fa...
(Date:10/3/2008)...h anthropologists and evolutionary biologists are ...ed in the open-access journal PLoS ONE, supports... have appeared tens of thousands of years before t...ties emerged rapidly through intense power struggl...umanity. In many mammals living in groups, includi...
Breaking Biology News(10 mins):Scientists Find new migratory patterns for Mediterranean and Western Atlantic bluefin tuna 2US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board 2Traits produced by melanin may signal the bearer's capacity to combat free radicals 2Egalitarian revolution in the Pleistocene? 2Egalitarian revolution in the Pleistocene? 3Egalitarian revolution in the Pleistocene? 4Joint Commission Alert 3A Prevent Pediatric Medication Errors 16564 1Joint Commission Alert 3A Prevent Pediatric Medication Errors 16564 2Joint Commission Alert 3A Prevent Pediatric Medication Errors 16564 3AEterna Zentaris Announces Changes to its Management Team 4539 1AEterna Zentaris Announces Changes to its Management Team 4539 2Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storag 4538 1Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storag 4538 2Status of the E2007 28perampanel 29 Development Program 1743 1Status of the E2007 28perampanel 29 Development Program 1743 2Status of the E2007 28perampanel 29 Development Program 1743 3Status of the E2007 28perampanel 29 Development Program 1743 4
...ician and scientist, who has spent the best part o...t HIV and AIDS throughout the world, is calling fo...rapid "feminization" of the AIDS pandemic. , Quinn...d a senior investigator at the National Institute ...men have in the last 20 years moved from being tho...
...cancer patients most likely to respond to the drug...nse to the drug cetuximab (Erbitux), according to ...e Journal of the National Cancer Institute. Both...mechanisms. , Some patients with non?small-cell l...dermal growth factor receptor (EGFR). This protein...
...nipulating energy regulation of cells, a collabora...as demonstrated that cells lacking a tumor-suppres... energy levels when they become stressed. This e...om dying off too quickly. The study,s results coul...r growth, but also type 2 diabetes and obesity. ,...
...atistically significant improvements in clinical m...osia on the Etiology, Pathogenesis and Treatment o...Neurologix,s Phase I trial showed positive interim...e year following treatment, patients exhibited a s...tion on the side of their body correlating to the ...
Other Biology News:AIDS expert says global strategy needed to combat feminization of HIV/AIDS 2AIDS expert says global strategy needed to combat feminization of HIV/AIDS 3Treatments have same target, different responses for lung cancer patients with genetic mutation 2Energy management in cells may hold key to cancer defense 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6
... Immunogen Synthetic peptide: ASGPMPAPPRQERKRTQDA...s 23-43 of Rat Kv4.2. Reactivity / Specificity C...Human (100% identity with immunogen), Mouse (100% ...th immunogen) and Ferret (100% identity with immun...
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array
Cryo/CryoPlus Inventory Racks for cryogenic vials. Racks are available with cardboard or stainless steel boxes for 2ml, 4ml, or 5ml cryo vials. Vapor phase or Liquid phase racks available. Platfor
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab
Biology Products: